MedTrace Logo

Mortality and Risk Factors in Patients With Acute Cardiogenic Pulmonary Edema: a Multicentric, Observational, Prospective Study

NCT01269177 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2011-01-04

No results posted yet for this study

Summary

The purpose of this study is to define the current treatment of patients ospitalized with acute cardiogenic pulmonary edema. Clinical and laboratory data collected in the Emergency Department will used to investigate the primary outcome (mortality) and risk factors related to the primary outcome.

Conditions

  • Pulmonary Edema
  • Respiratory Insufficiency

Interventions

DEVICE

Non invasive ventilation

Indications for the use of NIV are at least one of the following: * Respiratory Rate ≥ 30 bpm * PaO2/FiO2 \< 200 * pH \< 7.35 and PaCO2 \> 45 mmH Contraindications for the use of NIV are at least one of the following: * Coma * Hemodynamic instability / shock * Lack of compliance Indications for endotracheal intubation (ETI) are at least one of the following: * Respiratory or cardiac arrest * Coma * Hemodynamic instability

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Principal Investigators

  • Roberto Cosentini, MD · Ospedale Maggiore Policlinico Mangiagalli e Regina Elena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01269177 on ClinicalTrials.gov